Knowthestock.com
PODD - Insulet Corporation
SNP 500

Buy

Strong Growth and ImprovingStock Price Attractive
WeakStrong
WeakStrong

66%

based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 22.07%
Operating Income Growth is 40.41%
Net Income Growth is 102.76%
Earnings Per Share (EPS) Growth is 96.6%
Net Margin is 20.19%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 3.58
Debt Ratio is 0.61
Current Debt to Net Income Ratio is 0.2
Total Debt to Total Assets Ratio is 0.47
Cash Flow is MODERATE
Cash from Operations Growth is 195.33%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Insulet Corporation (PODD) - www.myomnipod.com
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Exchange - NASDAQ
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Shacey Petrovic
Employees - 2,600
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.